新鳳鳴(603225.SH)同意由中欣化纖吸收合併中馳化纖
格隆匯12月17日丨新鳳鳴(603225.SH)公佈,為進一步優化公司管理架構,簡化管理環節,簡化內部核算,提高運營效率,降低管理成本,公司於2019年12月17日召開第四屆董事會第三十六次會議,會議審議通過了《關於全資子公司之間吸收合併的議案》,同意由公司全資子公司桐鄉中欣化纖有限公司(“中欣化纖”)吸收合併全資子公司桐鄉市中馳化纖有限公司(“中馳化纖”),吸收合併完成後,中欣化纖作為吸收合併方存續經營,中馳化纖作為被吸收合併方依法予以註銷登記。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.